Nucific review

What it is

Nucific is a telehealth service founded by Dr. Amy Lee, MD, described on the site as triple board-certified in internal medicine, obesity medicine and clinical nutrition. Its catalogue is compounded semaglutide and tirzepatide, microdosed versions of both, brand-name Zepbound and Ozempic, and a longevity line of injectable sermorelin plus NAD⁺ in three routes — injection, oral liposomal liquid and nasal spray. Despite a brand history in consumer nutrition products, the site today is a prescription telehealth service: every product on it is a prescription treatment routed through a licensed provider, and no supplement is sold anywhere on it.

How it works

Quiz-led and asynchronous: a three-minute assessment, same-day approval if eligible, treatment shipped in discreet packaging from what the site calls licensed US pharmacies, and unlimited provider messaging afterwards. The presentation layer is where Nucific separates itself. The weight-loss claim is anchored to a named trial with the average and the citation attached and an explicit note that it is an illustrative average, not a personalised prediction. The NAD⁺ chart — the one every competitor draws without explanation — carries a methodology note stating that the curve is a simplified model, not a measurement of any individual, and that reported values and rates of decline differ across studies, tissues, sexes and measurement methods. The testimonial block states outright that the people featured were compensated for their time. That is a materially higher standard than the norm. What sits against it is verification: the LegitScript badge is a self-hosted image with generic alt text rather than the issued embed that hard-codes a verification link and seal ID, and the BBB accreditation claim carries no link to a profile. No state list is published and no pharmacy is named.

Pricing transparency

There is no published price anywhere on the site for anything — not for sermorelin, not for any of the three NAD⁺ routes, not for the compounded or brand GLP-1s. Every treatment card is a 'Get Started' or 'Take The Quiz' button, and the FAQ that asks whether there is a membership fee does not expose its answer without interaction. We are not going to estimate a number, so the honest summary is that Nucific cannot be price-compared before intake, and its own cancellation, commitment and refund terms are not published either. Before completing the assessment, ask what a month of sermorelin costs, whether the three NAD⁺ routes are priced differently, whether the price moves as a provider titrates you, whether there is a membership fee on top, and what the cancellation terms are. Those are five questions that most providers on this board answer on a product page.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Nucific's catalogue mixes compounded preparations, which are not reviewed by the FDA for purity and potency the way approved drugs are, with genuine brand-name Zepbound and Ozempic. The pharmacy is not named. On the evidence, its longevity line is weaker than its GLP-1 line, and to the site's credit its own copy is careful rather than overreaching. Sermorelin is a GHRH analogue that signals your own pituitary to release growth hormone rather than supplying it — a real, well-described mechanism, with thin long-term human outcome data behind the sleep, body-composition and healthy-aging claims made for it. NAD⁺ is the harder case: injected, intranasal and sublingual NAD⁺ have no controlled human outcome trials at all, and the oral liposomal route has none either. The NAD⁺ forms with human data are the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a raised biomarker, not a demonstrated clinical benefit — which is precisely why the site's own disclaimer about the decline curve being illustrative is the right call. Individual results vary.

Pros and watch-outs

The evidence behind what Nucific prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

How Nucific compares

A few alternatives worth a look, depending on what you’re optimizing for.

• NHNucore Health

  A flat, any-dose NAD⁺ price with no membership fee, nationwide

  See Nucore Health →
• NKNäky

  NAD⁺ at a rate that does not climb when a provider raises your dose

  See Näky →
• NINu Image Medical

  Choosing between injected, sublingual and intranasal sermorelin at one published rate

  See Nu Image Medical →